Pieris is a clinical stage biotechnology company advancing its proprietary Anticalin technology to create differentiated drugs that have the potential to be safer and more effective than conventional approaches. Anticalins show promise in addressing high unmet medical needs and expanding the potential of targeted therapeutics. The company currently has a diverse proprietary pipeline and has ongoing R amp D collaborations with Daiichi Sankyo, the Sanofi Group, Zydus Cadila, Stelis Biopharma and Allergan. For more information visit www.pieris.com.
Quote | Pieris Pharmaceuticals Inc. (NASDAQ:PIRS)
Last: | $8.68 |
---|---|
Change Percent: | 1.28% |
Open: | $8.775 |
Close: | $8.57 |
High: | $8.835 |
Low: | $8.68 |
Volume: | 1,450 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Pieris Pharmaceuticals Inc. (NASDAQ:PIRS)
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Message Board Posts | Pieris Pharmaceuticals Inc. (NASDAQ:PIRS)
Subject | By | Source | When |
---|---|---|---|
$PIRS .25 -71% | TheFinalCD | investorshub | 06/21/2023 5:41:31 PM |
we got news | rynlrt | investorshub | 06/18/2023 3:53:03 AM |
$PIRS MomentumIts now last up | ttottip | investorshub | 06/16/2023 8:17:29 PM |
are we finally gonna see some action | $oldier Hard | investorshub | 06/14/2023 7:26:42 PM |
$PIRS just the news we needed | $oldier Hard | investorshub | 06/13/2023 9:56:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Pieris Pharmaceuticals Inc. Company Name:
PIRS Stock Symbol:
NASDAQ Market:
Pieris Pharmaceuticals Inc. Website:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
2024-04-23 09:02:03 ET Pieris Pharmaceuticals Inc (PIRS) announced stock split at a ratio of 1-for-80 on 2024-04-23 ... Full story available on KlickAnalytics.com